New at ASHG

Thermo Fisher will be virtually presenting at the American Society on Human Genetics (Oct 27-30). These presentations are of particular interest around the theme "It's time to re-imagine healthcare together". Learn more about all our activities at ASHG this year.

MADCaP: The First Large Pan-African GWAS Tackling Cancer Health Disparities in African Populations
Timothy Rebbeck, PhD
Vincent L. Gregory, Jr. Professor of Cancer Prevention, Harvard TH Chan School of Public Health and Division of Population Sciences, Dana Farber Cancer Institute

How comprehensive pharmacogenomics accelerates personalized therapies and reduces health disparities for minorities
Dr. Ulrich Broeckel, MD Founder and CEO, RPRD Diagnostics

Preemptive PGx at population-scale: Implementation in Pittsburgh
Philip Empey, PharmD, PhD, Assoc. Director, Institute for Precision Medicine
Assoc Professor, Pharmacy & Therapeutics

Implementing a world-class clinical pharmacogenomics service
Dr. Hyun Kim, Clinical Pharmacist, Clinical Pharmacogenomics Service, Boston Children's Hospital

Polygenic Risk Scores - Value & Path into the Clinic

Sir Peter Donnelly (Founder, Genomic plc) & Dr. Jill Hagenkord (VP Genomics, Optum) share the stage in a presentation and panel discussion on incorporating polygenic risk scores and application in the clinic

Accurate Pharmacogenomics Testing – A Market Overview

This whitepaper summarizes the pharmacogenomics (PGx) landscape addressing regulations, global population coverage, complexity of PGx markers

Host Genetics with the new Axiom Human Genotyping SARS-CoV-2 Research Array

This webinar discusses a new whole-genome SARS-CoV-2 array to help understand how coronavirus interacts with the human genome and to stratify populations in order to understand disease susceptibility, severity, and outcomes.

Complete the short form below to obtain access to the hub.

(*Indicates a mandatory field)